Age-related macular degeneration (AMD) affects more than 5 million people around the world.
And until now, no treatment could restore their vision.
The Prima system, which was approved in Europe in July and is awaiting FDA clearance in the US, changes that.
It combines a retinal implant with camera-equipped eyeglasses to improve sight in patients who develop a blind spot in the middle of their vision due to advanced AMD.
Stay updated with continuous reporting from MIT Tech Review.